investorscraft@gmail.com

Intrinsic ValueTreatt plc (TET.L)

Previous Close£204.00
Intrinsic Value
Upside potential
Previous Close
£204.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Treatt plc operates in the specialty chemicals sector, focusing on natural extracts and ingredients for the flavor, fragrance, beverage, and consumer product industries. The company’s core revenue model is built on supplying high-value, natural ingredients such as citrus, coffee, tea, and health-focused extracts, as well as aroma chemicals and floral ingredients. Its diversified product portfolio caters to global demand for clean-label and sustainable solutions, positioning it as a key supplier to multinational beverage and consumer goods companies. Treatt’s market position is strengthened by its long-standing expertise, traceable supply chains, and innovation in natural ingredient applications. The company serves a broad geographic footprint, including the UK, US, China, and Europe, aligning with trends toward healthier and more transparent product formulations. Its focus on R&D and customer collaboration allows it to maintain a competitive edge in a niche but growing segment of the specialty chemicals industry.

Revenue Profitability And Efficiency

Treatt reported revenue of £153.1 million (GBp) for the latest fiscal period, with net income of £14.4 million (GBp), reflecting a margin of approximately 9.4%. Operating cash flow stood at £21.1 million (GBp), indicating efficient cash generation, while capital expenditures of £5.4 million (GBp) suggest moderate reinvestment needs. The company’s profitability metrics demonstrate stable operational execution in a competitive market.

Earnings Power And Capital Efficiency

Diluted EPS of 0.23 (GBp) underscores Treatt’s earnings power, supported by its focus on premium natural ingredients. The company’s capital efficiency is evident in its ability to generate positive operating cash flow (£21.1 million GBp) despite a capital-intensive R&D and supply chain model. Its moderate debt levels (£2.5 million GBp) further highlight prudent financial management.

Balance Sheet And Financial Health

Treatt maintains a conservative balance sheet, with £1.8 million (GBp) in cash and equivalents and total debt of £2.5 million (GBp). The low leverage ratio and healthy operating cash flow position the company to fund growth initiatives without significant financial strain. Its financial health is further supported by a manageable debt profile and liquidity reserves.

Growth Trends And Dividend Policy

The company has demonstrated consistent growth in revenue and profitability, driven by demand for natural ingredients. Its dividend per share of 8.41 (GBp) reflects a commitment to shareholder returns, balanced against reinvestment needs. Treatt’s growth trajectory aligns with broader industry trends favoring sustainable and clean-label products.

Valuation And Market Expectations

With a market cap of £169.0 million (GBp) and a beta of 1.19, Treatt is viewed as a moderately volatile stock with growth potential. The valuation reflects investor confidence in its niche market positioning and ability to capitalize on trends in natural and sustainable ingredients.

Strategic Advantages And Outlook

Treatt’s strategic advantages lie in its specialized product portfolio, global supply chain, and strong customer relationships. The outlook remains positive, supported by increasing demand for natural flavors and fragrances. However, the company faces risks from raw material price volatility and competitive pressures in the specialty chemicals sector.

Sources

Company filings, London Stock Exchange data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount